<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00150163</url>
  </required_header>
  <id_info>
    <org_study_id>015</org_study_id>
    <nct_id>NCT00150163</nct_id>
  </id_info>
  <brief_title>Odense Androgen Study: Study of Androgens, Body Composition, and Muscle Function in Danish Men</brief_title>
  <official_title>Odense Androgen Study - A Population-Based Study of Androgens, Body Composition, and Muscle Function in 20-29 Year-Old Danish Men</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Odense University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Odense University Hospital</source>
  <brief_summary>
    <textblock>
      Objective:&#xD;
&#xD;
        -  To define a reference-population of healthy young men (20-29 years old).&#xD;
&#xD;
        -  To establish reference-intervals for:&#xD;
&#xD;
             1. Total, bioavailable and free serum androgens (testosterone, dihydrotestosterone,&#xD;
                androstenedione) and serum estrogens (estradiol, estrone).&#xD;
&#xD;
             2. Total and free IGF-1.&#xD;
&#xD;
        -  To study the influence of physical activity, alcohol intake, tobacco and abuse of&#xD;
           anabolic steroids on serum levels of androgens.&#xD;
&#xD;
        -  To identify the androgens (or estrogens) that primarily reflect the following&#xD;
           parameters:&#xD;
&#xD;
             1. Muscle mass, muscle strength, muscle power, oxygen uptake, and hematocrit.&#xD;
&#xD;
             2. Bone mineral density and bone metabolism.&#xD;
&#xD;
             3. Total and visceral fat mass.&#xD;
&#xD;
             4. Lipid- and glucose metabolism and glucocorticoid metabolism.&#xD;
&#xD;
             5. Sexual function and quality of life.&#xD;
&#xD;
        -  To study the modifying effect of birth weight, the AR gene CAG-repeat polymorphism, and&#xD;
           the level of IGF-1 on associations between serum androgens and the measures above:&#xD;
&#xD;
      Ethics, design and schedule:&#xD;
&#xD;
      The local ethic review board approved a population-based, cross-sectional study planned for&#xD;
      the inclusion of 800 Caucasian men, 20 to 29 year old, living in the County of Funen. The&#xD;
      only exclusion criteria were opioid drug addiction, cancer, and severe chronic disease. A&#xD;
      basic questionnaire was mailed to 3000 men, randomly drawn from the Danish Central Personal&#xD;
      Registry. Adequately answered questionnaires were returned from 2,199 men, who subsequently&#xD;
      received an invitation to participate. Informed consent was obtained from 783 men. The&#xD;
      examinations started in March 2002 and terminated in May 2003. Within subject variation was&#xD;
      determined for all study parameters in 20 men. The men included matched the men answering the&#xD;
      questionnaire on all questionnaire items and demographics. All analyses have been performed,&#xD;
      except for the additional serum sex hormone assays, IGF-1 assays and AR gene analyses.&#xD;
&#xD;
      A sequential rule-out from the reference population was performed on the following criteria:&#xD;
&#xD;
        1. testicular pathology: bilateral cryptorchidism, varicocele, testes volumina &lt; 10 ml&#xD;
           (each), history of spermatic cord torsion.&#xD;
&#xD;
        2. severe chronic disease.&#xD;
&#xD;
        3. regular medication or abuse of anabolic steroids.&#xD;
&#xD;
        4. body mass index &lt; 19 kg/m2.&#xD;
&#xD;
        5. safety serum parameters: luteinizing hormone (LH) &lt;1.0 U/L or &gt;8.4 U/l,&#xD;
           alanine-amino-transferase (ALAT) &gt;70 U/l and thyrotropin (TSH) &gt;6.0 mU/l.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>March 2002</start_date>
  <completion_date>December 2008</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment>800</enrollment>
  <condition>Bone Diseases</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age: 20-29 years&#xD;
&#xD;
          -  Residence: County of Funen, Denmark&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Opioid drug addiction&#xD;
&#xD;
          -  Cancer&#xD;
&#xD;
          -  Severe chronic disease&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>29 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Torben L. Nielsen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Odense University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Endocrinology, Odense University Hospital</name>
      <address>
        <city>Odense</city>
        <state>Funen</state>
        <zip>5000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <results_reference>
    <citation>Nielsen TL, Wraae K, Brixen K, Hermann AP, Andersen M, Hagen C. Prevalence of overweight, obesity and physical inactivity in 20- to 29-year-old, Danish men. Relation to sociodemography, physical dysfunction and low socioeconomic status: the Odense Androgen Study. Int J Obes (Lond). 2006 May;30(5):805-15.</citation>
    <PMID>16418764</PMID>
  </results_reference>
  <verification_date>September 2005</verification_date>
  <study_first_submitted>September 6, 2005</study_first_submitted>
  <study_first_submitted_qc>September 6, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 8, 2005</study_first_posted>
  <last_update_submitted>March 28, 2007</last_update_submitted>
  <last_update_submitted_qc>March 28, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 29, 2007</last_update_posted>
  <keyword>Androgens</keyword>
  <keyword>Bone</keyword>
  <keyword>Muscle</keyword>
  <keyword>Estrogens</keyword>
  <keyword>Fat</keyword>
  <keyword>Lipid and glucose metabolism</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bone Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

